APT Medical (SHA:688617) has an average rating of buy and mean price target of 335.39 yuan, according to analysts polled by FactSet.
What else is happening in Research?
Research
Barrington Initiates CBIZ at Outperform With $45 Price Target
CBIZ (CBZ) has an average rating of overweight and mean price target of $41.80, according to analysts polled by FactSet.Price: $30.50, Change: $+0.10, Percent Change: +0.33%
$CBZ
Research
Stifel Downgrades Apogee Therapeutics to Hold From Buy, Adjusts Price Target to $135 From $133
Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $132.64, according to analysts polled by FactSet.Price: $132.93, Change: $+0.05, Percent Change: +0.04%
$APGE
Research
Rothschild & Co Redburn Cuts TUI Group's PT, Affirms Buy Rating
Rothschild & Co Redburn on Wednesday lowered the price target for German travel services company TUI Group (TUI1.F) to 11.00 euros from 13.60 euros and kept its rating at buy.
$TUI1.F